Xtant Medical Holdings, Inc.
XTNT- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001453593
No open-market purchases or sales by Xtant Medical Holdings, Inc. insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $33.8M in total; no superinvestor holds it.
13F holders, Q4 2022
Institutional positions in Xtant Medical Holdings, Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 19
- +2 vs. Q3 2022
- Shares held
- 81.9M
- +219.8K (+0.3%) vs. Q3 2022
- Total value
- $54.1M
- −$4.74M (−8.1%) vs. Q3 2022
- New holders
- 4
- 4 more added
- Sold out
- 2
- 2 more reduced
1 institution that held it in Q3 2022 haven't filed for Q4 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting XTNT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 32 | $33.8M |
| Q1 2026 | 34 | $45.1M |
| Q4 2025 | 35 | $63.8M |
| Q3 2025 | 30 | $52.0M |
| Q2 2025 | 30 | $59.1M |
| Q1 2025 | 28 | $45.3M |
| Q4 2024 | 30 | $42.8M |
| Q3 2024 | 28 | $66.1M |
| Q2 2024 | 27 | $56.7M |
| Q1 2024 | 33 | $105.7M |
| Q4 2023 | 31 | $101.9M |
| Q3 2023 | 28 | $99.3M |
| Q2 2023 | 19 | $76.0M |
| Q1 2023 | 21 | $52.2M |
| Q4 2022 | 19 | $54.1M |
| Q3 2022 | 18 | $58.8M |
| Q2 2022 | 18 | $41.9M |
| Q1 2022 | 19 | $54.8M |
| Q4 2021 | 22 | $45.2M |
| Q3 2021 | 17 | $89.4M |
| Q2 2021 | 20 | $134.8M |
| Q1 2021 | 21 | $175.8M |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Xtant Medical Holdings, Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| OrbiMed Advisors LLC | 73,114,592 | $48.3M | 0.92% | 00.0% | Unchanged |
| Altium Capital Management LP | 6,246,291 | $4.12M | 2.11% | 00.0% | Unchanged |
| Vanguard Group Inc | 1,278,952 | $844.1K | 0.00% | +161,042+14.4% | Added |
| Renaissance Technologies LLC | 606,310 | $400.0K | 0.00% | −20,900−3.3% | Reduced |
| Crescent Grove Advisors, LLC | 262,024 | $172.9K | 0.02% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 114,500 | $75.6K | 0.00% | 00.0% | Unchanged |
| CWM, LLC | 100,000 | $66.0K | 0.00% | 00.0% | Unchanged |
| Citadel Advisors LLC | 43,658 | $28.8K | 0.00% | +43,658 | New |
| Midwest Professional Planners, LTD. | 40,744 | $26.9K | 0.01% | 00.0% | Unchanged |
| Millennium Management LLC | 25,795 | $17.0K | 0.00% | +25,795 | New |
| State Street Corp | 23,666 | $15.6K | 0.00% | 00.0% | Unchanged |
| Geode Capital Management, LLC | 23,593 | $15.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 21,061 | $13.9K | 0.00% | +21,061 | New |
| UBS Group AG | 1,351 | $892 | 0.00% | +1,351 | New |
| Morgan Stanley | 311 | $205 | 0.00% | +281+936.7% | Added |
| Advisor Group Holdings, Inc. | 316 | $192 | 0.00% | +290+1,115.4% | Added |
| Wells Fargo & Company | 193 | $128 | 0.00% | +105+119.3% | Added |
| BlackRock Inc. | 143 | $94 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 33 | $22 | 0.00% | −864−96.3% | Reduced |
| Tower Research Capital LLC (TRC) | 0 | $0 | 0.00% | −11,914−100.0% | Sold out |
| FMR LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| American Portfolios Advisors | – | – | – | – | Not filed |